Search company, investor...

Predict your next investment

Corporate Venture
FINANCE | Investment Firms & Funds
kpventures.com

Investments

170

Portfolio Exits

41

Funds

7

Partners & Customers

2

Service Providers

1

About Kaiser Permanente Ventures

Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, invests in medical devices, health care services and health care information technology companies.

Headquarters Location

One Kaiser Plaza 22nd Floor

Oakland, California, 94612,

United States

510-267-7300

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Kaiser Permanente Ventures News

Gynesonics: Women’s Healthcare Company Secures $67 Million

Nov 28, 2023

Gynesonics – a women’s healthcare company focused on developing minimally invasive solutions for symptomatic uterine fibroids – recently announced that it has secured an incremental $42.5 million in financing (total of $67.2 million inclusive of initial April 2023 financing). The funding round was led by existing Gynesonics investors Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital, with new investments coming from MVM Partners and several other healthcare investors excited about Gynesonics’ commercial advances. As pioneers in women’s health, Gynesonics is committed to developing and delivering minimally invasive, incision-free, uterus-preserving, transcervical technologies for diagnostic and therapeutic applications. And Gynesonics’ flagship product – the Sonata System – is the first FDA-cleared medical device for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, a medical condition affecting roughly 80% of adult women. Before the Sonata System, fibroid removal was limited to invasive medical procedures, like a hysterectomy, which carries greater risk and significantly more recovery time. KEY QUOTES: “Gynesonics continues to lay a strong foundation for success, having achieved a number of important commercial milestones in the most recent quarters. The company is very well positioned to continue the acceleration of its growth going forward. Amzak Health and our fellow Gynesonics investors are very excited about the company’s prospects to become the leading long-term solution in the treatment of symptomatic fibroids.” — Joyce Erony, General Partner, Amzak Health “Uterine fibroids cause suffering to millions of women. MVM is glad to support Gynesonics in offering a uterus-preserving, incisionless alternative to hysterectomy and myomectomy.” — Hugo Harrod of MVM Partners “This funding will enable Gynesonics to continue to expand commercial operations and provide millions of patients suffering from symptomatic fibroids a safe and efficacious minimally invasive treatment. With 275M+ U.S. covered lives (including 19 of the top 20 commercial payers) covering Sonata and our new Category 1 code going live in January, we are excited to accelerate our commercial efforts in the U.S. as well as Europe.” — Skip Baldino, President and CEO of Gynesonics Sponsors

Kaiser Permanente Ventures Investments

170 Investments

Kaiser Permanente Ventures has made 170 investments. Their latest investment was in Abridge as part of their Series B on October 10, 2023.

CBI Logo

Kaiser Permanente Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/26/2023

Series B

Abridge

$30M

Yes

4

6/22/2023

Series C - II

Everytable

$25M

No

3

6/21/2023

Series C

DexCare

$75M

No

11

4/11/2023

Series H

Subscribe to see more

$99M

Subscribe to see more

10

1/31/2023

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/26/2023

6/22/2023

6/21/2023

4/11/2023

1/31/2023

Round

Series B

Series C - II

Series C

Series H

Series C

Company

Abridge

Everytable

DexCare

Subscribe to see more

Subscribe to see more

Amount

$30M

$25M

$75M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

3

11

10

10

Kaiser Permanente Ventures Portfolio Exits

41 Portfolio Exits

Kaiser Permanente Ventures has 41 portfolio exits. Their latest portfolio exit was Nuvolo on October 02, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/2/2023

Acquired

$99M

2

6/1/2022

Acquired

$99M

3

8/25/2021

Merger

$99M

10

6/29/2021

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/2/2023

6/1/2022

8/25/2021

6/29/2021

5/21/2021

Exit

Acquired

Acquired

Merger

Acq - Fin

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

3

10

10

10

Kaiser Permanente Ventures Fund History

7 Fund Histories

Kaiser Permanente Ventures has 7 funds, including Kaiser Permanente Ventures V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/5/2019

Kaiser Permanente Ventures V

Multi-Stage Venture Capital

Closed

$141M

3

6/30/2008

KP Healthcare Fund V

Subscribe to see more

Subscribe to see more

$99M

10

10/1/2006

Kaiser Permanente Healthcare Fund IV

Subscribe to see more

Subscribe to see more

$99M

10

3/30/2005

Kaiser Permanente Healthcare Fund III

Subscribe to see more

Subscribe to see more

$99M

10

7/31/2004

Kaiser Permanente Healthcare Side Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/5/2019

6/30/2008

10/1/2006

3/30/2005

7/31/2004

Fund

Kaiser Permanente Ventures V

KP Healthcare Fund V

Kaiser Permanente Healthcare Fund IV

Kaiser Permanente Healthcare Fund III

Kaiser Permanente Healthcare Side Fund

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$141M

$99M

$99M

$99M

$99M

Sources

3

10

10

10

10

Kaiser Permanente Ventures Partners & Customers

2 Partners and customers

Kaiser Permanente Ventures has 2 strategic partners and customers. Kaiser Permanente Ventures recently partnered with Unite Us on May 5, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

5/30/2019

Partner

United States

Event Recap – Community-Wide Collaboration Between the Health Care & Social Sectors - KP Ventures

To read more about the Unite Us partnership with Kaiser Permanente Ventures on Thrive Local , please read here .

1

4/23/2019

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

5/30/2019

4/23/2019

Type

Partner

Partner

Business Partner

Country

United States

United States

News Snippet

Event Recap – Community-Wide Collaboration Between the Health Care & Social Sectors - KP Ventures

To read more about the Unite Us partnership with Kaiser Permanente Ventures on Thrive Local , please read here .

Subscribe to see more

Subscribe to see more

Sources

1

10

Kaiser Permanente Ventures Service Providers

1 Service Provider

Kaiser Permanente Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

Kaiser Permanente Ventures Team

3 Team Members

Kaiser Permanente Ventures has 3 team members, including current Managing Director, Amy Belt Raimundo.

Name

Work History

Title

Status

Amy Belt Raimundo

Evidation, Covidien Ventures, Medtronic, Advanced Technology Ventures, and Guidant Global

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Amy Belt Raimundo

Subscribe to see more

Subscribe to see more

Work History

Evidation, Covidien Ventures, Medtronic, Advanced Technology Ventures, and Guidant Global

Title

Managing Director

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Compare Kaiser Permanente Ventures to Competitors

H
H&S Tech

H&S Tech is a manufacturer and distributor of disposable packaging and medical products from South Korea and China. It supplies general to custom products for government sectors, retail sectors, and food distribution sectors. The company delivers within the United States. It was founded in 2019 and is based in Anaheim, California.

Panda Health Logo
Panda Health

Panda Health is a company that operates in the digital health sector, focusing on facilitating connections between health systems and digital health companies. The company offers a platform that aids in the exploration and adoption of leading digital health technologies, providing insights backed by extensive data, solution evaluations, and market intelligence. Panda Health primarily serves the healthcare industry. It was founded in 2020 and is based in Atlanta, Georgia.

M
Marche Health

Marche Health is a digital health marketplace operating in the healthcare and technology sectors. The company provides a platform for the evaluation and adoption of digital health initiatives, connecting healthcare systems, digital health vendors, healthcare payers, pharmaceutical companies, investors, and consultants. It primarily serves the healthcare industry. It was founded in 2020 and is based in New York, New York.

Zelis Logo
Zelis

Zelis operates as a company focusing on modernizing the business of healthcare. It offers a platform that aims to bridge gaps in the healthcare financial system, providing solutions to healthcare networks, ensure regulatory compliance, manage out-of-network costs, and improve payment integrity. It primarily serves the healthcare industry, with key customer segments including healthcare insurers, providers, and consumers. Zelis was formerly known as Stratose. The company was founded in 1995 and is based in Bedminster, New Jersey.

Capital Rx Logo
Capital Rx

Capital Rx provides a healthcare technology company. It offers a pharmacy benefits management (PBM) platform that reduces administrative costs, improves patient outcomes, and delivers a superior customer experience. It also offers prescription savings cards. The company was founded in 2017 and is based in New York, New York.

Pharma Connections Worldwide Logo
Pharma Connections Worldwide

Looking for private equity investors for drug development, medical devices, nutraceuticals and healthcare IT technology

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.